SAFE, STRAIGHTFORWARD, SIMPLE.

Break free from frequent and sometimes painful self-insertions weekly or bi-weekly. The Eversense sensor is carefully placed under the skin by a trained health care provider and lasts up to 6 months.

HERE'S WHAT YOU CAN EXPECT

We understand getting any type of procedure can be stressful. That's why we make the insertion and removal process as simple, pain-free and safe as possible. It usually takes just a few minutes.

84PercentCircle.png

of users would choose to be inserted again1

  • Two brief office visits per year to insert and remove the sensor in just several minutes
  • Insertion and removal process normally takes a few minutes each
  • Most insertions and removals heal within a few days
GET STARTED NOW

TWO SIMPLE IN-OFFICE PROCEDURES. UP TO 6 MONTHS OF CONTINUOUS GLUCOSE MONITORING.

Sensor Insertion

Step One

~5 mm incision in upper arm under local aneesthesia

Step Two

Sensor inserted with custom inserter

Step Three

Steri-strips™ to close

Sensor Removal

Step One

5-6 mm incision in upper arm under local anesthetic

Step Two

Sensor removed with clamp

Step Three

Steri-strips® to close

GO TO SENSOR

"THE SENSOR PLACEMENT
WENT REALLY WELL. I FELT NOTHING...**"

- Roberta, Eversense CGM User -

HEAR MORE STORIES

*Up to 6 months
**The opinions expressed belong solely to the individual. This information provides general information only. It is not intended to be used as medical advice, diagnosis or treatment and should not replace the advice of a Health Care Provider.

1. Barnard et al. Acceptability of Implantable Continuous Glucose Monitoring Sensor. Journal of Diabetes Science and Technology 2018, Vol. 12(3) 634–638.

Disclaimer

The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For safety information click here.

Eversense, Eversense E3 Continuous Glucose Monitoring and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, and the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.

Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.